Ethyl pyruvate attenuates formalin-induced inflammatory nociception by inhibiting neuronal ERK phosphorylation

Molecular Pain

Volumn 8, Issue , 2012, Pages

  Lee, Min J ^a   Jang, Minhee ^a   Jung, Hyuk Sang ^a   Kim, Sung Hoon ^a   Cho, Ik Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

c Fos; Ethyl pyruvate; Inflammatory nociception; PD 98059; Phospho ERK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANALGESIC AGENT; FORMALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME PHOSPHORYLATION; IMMUNOREACTIVITY; INFLAMMATORY PAIN; MALE; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL;

ANIMALS; ANTIGENS, CD11; CELL SHAPE; EDEMA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; FORMALDEHYDE; INFLAMMATION; INJECTIONS, SPINAL; MALE; MICROGLIA; NEURONS; NOCICEPTION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84861438661     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-8-40     Document Type: Article

References (66)

1. Fink MP. Ethyl pyruvate: a novel anti-inflammatory agent. J Intern Med 2007, 261(4):349-362. 10.1111/j.1365-2796.2007.01789.x, 17391109.
2. Kao KK, Fink MP. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol 2010, 80(2):151-159. 10.1016/j.bcp.2010.03.007, 20230800.
3. Cai B, Deitch EA, Ulloa L. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediat Inflamm 2010, 2010:642462.
4. Cheng BQ, Liu CT, Li WJ, Fan W, Zhong N, Zhang Y, Jia XQ, Zhang SZ. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas 2007, 35(3):256-261. 10.1097/MPA.0b013e318064678a, 17895847.
5. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 2002, 99(19):12351-12356. 10.1073/pnas.192222999, 129448, 12209006.
6. Kim JB, Yu YM, Kim SW, Lee JK. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 2005, 1060(1-2):188-192.
7. Kim SW, Jeong JY, Kim HJ, Seo JS, Han PL, Yoon SH, Lee JK. Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain. Neurotox Res 2010, 17(1):39-49. 10.1007/s12640-009-9075-4, 19636661.
8. Moro N, Sutton RL. Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat. Exp Neurol 2010, 225(2):391-401. 10.1016/j.expneurol.2010.07.013, 2939141, 20670624.
9. Tokumaru O, Kuroki C, Yoshimura N, Sakamoto T, Takei H, Ogata K, Kitano T, Nisimaru N, Yokoi I. Neuroprotective effects of ethyl pyruvate on brain energy metabolism after ischemia-reperfusion injury: a 31P-nuclear magnetic resonance study. Neurochem Res 2009, 34(4):775-785. 10.1007/s11064-008-9871-x, 18985448.
10. Choi JS, Lee MS, Jeong JW. Ethyl pyruvate has a neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson's disease model. Biochem Biophys Res Commun 2010, 394(3):854-858. 10.1016/j.bbrc.2010.03.105, 20307492.
11. Huh SH, Chung YC, Piao Y, Jin MY, Son HJ, Yoon NS, Hong JY, Pak YK, Kim YS, Hong JK, Hwang O, Jin BK. Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease. J Immunol 2011, 187(2):960-969. 10.4049/jimmunol.1100009, 21685323.
12. Shen H, Hu X, Liu C, Wang S, Zhang W, Gao H, Stetler RA, Gao Y, Chen J. Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms. Neurobiol Dis 2010, 37(3):711-722. 10.1016/j.nbd.2009.12.010, 2824008, 20026271.
13. Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Caminiti R, Bramanti P, Fink MP, Cuzzocrea S. Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injury. Shock 2009, 32(2):217-227. 10.1097/SHK.0b013e31818d4073, 18948848.
14. Wang Q, Ding Q, Zhou Y, Gou X, Hou L, Chen S, Zhu Z, Xiong L. Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits. Anesthesiology 2009, 110(6):1279-1286. 10.1097/ALN.0b013e3181a160d6, 19417608.
15. Lee EJ, Kim HS. Inhibitory mechanism of MMP-9 gene expression by ethyl pyruvate in lipopolysaccharide-stimulated BV2 microglial cells. Neurosci Lett 2011, 493(1-2):38-43.
16. Song M, Kellum JA, Kaldas H, Fink MP. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J Pharmacol Exp Ther 2004, 308:307-316.
17. Cho IH, Kim SW, Kim JB, Kim TK, Lee KW, Han PL, Lee JK. Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Neurosci Res 2006, 84(7):1505-1511. 10.1002/jnr.21052, 16958132.
18. Kim HS, Cho IH, Kim JE, Shin YJ, Jeon JH, Kim Y, Yang YM, Lee KH, Lee JW, Lee WJ, Ye SK, Chung MH. Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. Free Radic Biol Med 2008, 45(7):950-963. 10.1016/j.freeradbiomed.2008.06.009, 18625301.
19. Ji RR, Befort K, Brenner GJ, Woolf CJ. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci 2002, 22(2):478-485.
20. Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 1999, 2(12):1114-1119. 10.1038/16040, 10570489.
21. Ma W, Quirion R. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin Ther Targets 2005, 9(4):699-713. 10.1517/14728222.9.4.699, 16083338.
22. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987, 328(6131):632-634. 10.1038/328632a0, 3112583.
23. Zhang XJ, Li Z, Chung EK, Zhang HQ, Xu HX, Sung JJ, Bian ZX. Activation of extracellular signal-regulated protein kinase is associated with colorectal distension-induced spinal and supraspinal neuronal response and neonatal maternal separation-induced visceral hyperalgesia in rats. J Mol Neurosci 2009, 37(3):274-287. 10.1007/s12031-008-9134-y, 18649147.
24. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytess by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114(1-2):149-159.
25. Seino D, Tokunaga A, Tachibana T, Yoshiya S, Dai Y, Obata K, Yamanaka H, Kobayashi K, Noguchi K. The role of ERK signaling and the P2X receptor on mechanical pain evoked by movement of inflamed knee joint. Pain 2006, 123(1-2):193-203.
26. Galan A, Cervero F, Laird JM. Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain. Brain Res Mol Brain Res 2003, 116(1-2):126-134.
27. Ji RR, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60(1):135-148. 10.1016/j.brainresrev.2008.12.011, 2666786, 19150373.
28. Cho IH, Chung YM, Park CK, Park SH, Li HY, Kim D, Piao ZG, Choi SY, Lee SJ, Park K, Kim JS, Jung SJ, Oh SB. Systemic administration of minocycline inhibits formalin-induced inflammatory pain in rat. Brain Res 2006, 1072(1):208-214. 10.1016/j.brainres.2005.12.039, 16427032.
29. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992, 51(1):5-17. 10.1016/0304-3959(92)90003-T, 1454405.
30. Fu KY, Light AR, Maixner W. Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin. Neuroscience 2000, 101(4):1127-1135. 10.1016/S0306-4522(00)00376-6, 11113361.
31. Coggeshall RE. Fos, nociception and the dorsal horn. Prog Neurobiol 2005, 77(5):299-352.
32. Curran T, Morgan JI. Fos: an immediate-early transcription factor in neurons. J Neurobiol 1995, 26(3):403-412. 10.1002/neu.480260312, 7775973.
33. Harris JA. Using c-fos as a neural marker of pain. Brain Res Bull 1998, 45(1):1-8. 10.1016/S0361-9230(97)00277-3, 9434195.
34. Paxinos G. The Rat Nervous System 1995, Elsevier Elsevier, Philadelphia.
35. Willis WD, Coggeshall RE. Sensory mechanisms of the spinal cord 2004, Kluwer academic/plenum publishers, New York.
36. Thomas KL, Hunt SP. The regional distribution of extracellularly regulated kinase-1 and - 2 messenger RNA in the adult rat central nervous system. Neuroscience 1993, 56(3):741-757. 10.1016/0306-4522(93)90371-L, 8255431.
37. Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007, 3:33. 10.1186/1744-8069-3-33, 2186318, 17974036.
38. Svensson CI, Marsala M, Westerlund A, Calcutt NA, Campana WM, Freshwater JD, Catalano R, Feng Y, Protter AA, Scott B, Yaksh TL. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 2003, 86(6):1534-1544. 10.1046/j.1471-4159.2003.01969.x, 12950462.
39. Hong J, Cho IH, Kwak KI, Suh EC, Seo J, Min HJ, Choi SY, Kim CH, Park SH, Jo EK, Lee S, Lee KE, Lee SJ. Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J Biol Chem 2010, 285(50):39447-39457. 10.1074/jbc.M110.132522, 2998094, 20923777.
40. Fu KY, Light AR, Matsushima GK, Maixner W. Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res 1999, 825(1-2):59-67.
41. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987, 30(1):103-114. 10.1016/0304-3959(87)90088-1, 3614974.
42. Brain SD, Moore PK. Pain and neurogenic inflammation 1999, Birkhauser Verlag, Basel/Boston/Berlin.
43. Yu YM, Kim JB, Lee KW, Kim SY, Han PL, Lee JK. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 2005, 36(10):2238-2243. 10.1161/01.STR.0000181779.83472.35, 16141417.
44. Jang IS, Park MY, Shin IW, Sohn JT, Lee HK, Chung YK. Ethyl pyruvate has antiinflammatory and delayed myocardial protective effects after regional ischemia/reperfusion injury. Yonsei Med J 2010, 51(6):838-844. 10.3349/ymj.2010.51.6.838, 2995973, 20879048.
45. Sorkin LS, Moore J, Boyle DL, Yang L, Firestein GS. Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp Neurol 2003, 184(1):162-168. 10.1016/S0014-4886(03)00102-X, 14637089.
46. Wheeler-Aceto H, Porreca F, Cowan A. The rat paw formalin test: comparison of noxious agents. Pain 1990, 40(2):229-238. 10.1016/0304-3959(90)90073-M, 2308768.
47. Carmichael NM, Dostrovsky JO, Charlton MP. Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain 2010, 149(2):124-316.
48. Karim F, Wang CC, Gereau RW. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001, 21(11):3771-3779.
49. Karim F, Hu HJ, Adwanikar H, Kaplan D, Gereau RW. Impaired inflammatory pain and thermal hyperalgesia in mice expressing neuron-specific dominant negative mitogen activated protein kinase kinase (MEK). Mol Pain 2006, 16(2):2.
50. Kawasaki Y, Kohno T, Zhuang ZY, Brenner GJ, Wang H, Van Der Meer C, Befort K, Woolf CJ, Ji RR. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 2004, 24(38):8310-8321. 10.1523/JNEUROSCI.2396-04.2004, 15385614.
51. Yu YQ, Chen J. Activation of spinal extracellular signaling-regulated kinases by intraplantar melittin injection. Neurosci Lett 2005, 381(1-2):194-198.
52. Adwanikar H, Karim F, Gereau RW. Inflammation persistently enhances nocifensive behaviors mediated by spinal group I mGluRs through sustained ERK activation. Pain 2004, 111(1-2):125-135.
53. Cruz CD, Neto FL, Castro-Lopes J, McMahon SB, Cruz F. Inhibition of ERK phosphorylation decreases nociceptive behaviour in monoarthritic rats. Pain 2005, 116(3):411-419. 10.1016/j.pain.2005.05.031, 15979799.
54. Tsuda M, Ueno H, Kataoka A, Tozaki-Saitoh H, Inoue K. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia 2008, 56(4):378-386. 10.1002/glia.20623, 18186080.
55. Zhao P, Waxman SG, Hains BC. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J Neurosci 2007, 27(33):8893-8902. 10.1523/JNEUROSCI.2209-07.2007, 17699671.
56. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997, 71(3):225-235. 10.1016/S0304-3959(97)03369-1, 9231865.
57. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003, 23(10):4017-4022.
58. Ma W, Quirion R. Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytess in the lumbar spinal dorsal horn and the gracile nucleus. Pain 2002, 99(1-2):175-184.
59. Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR, Decosterd I, Ji RR. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytess for neuropathic pain development and maintenance. J Neurosci 2006, 26(13):3551-3560. 10.1523/JNEUROSCI.5290-05.2006, 16571763.
60. Li K, Lin T, Cao Y, Light AR, Fu KY. Peripheral formalin injury induces 2 stages of microglial activation in the spinal cord. J Pain 2010, 11(11):1056-1065. 10.1016/j.jpain.2010.01.268, 20488758.
61. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16(2):109-110. 10.1016/0304-3959(83)90201-4, 6877845.
62. Di Paola R, Mazzon E, Genovese T, Crisafulli C, Bramanti P, Caminiti R, Esposito E, Fink MP, Cuzzocrea S. Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice. Crit Care Med 2009, 37(1):270-282. 10.1097/CCM.0b013e318192fa63, 19050619.
63. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004, 107(1-2):125-133.
64. Cho IH, Hong J, Suh EC, Kim JH, Lee H, Lee JE, Lee S, Kim CH, Kim DW, Jo EK, Lee KE, Karin M, Lee SJ. Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain 2008, 131(Pt 11):3019-3033. 2577806, 18819987.
65. Piao ZG, Cho IH, Park CK, Hong JP, Choi SY, Lee SJ, Lee S, Park K, Kim JS, Oh SB. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 2006, 121(3):219-231. 10.1016/j.pain.2005.12.023, 16495005.
66. Mestre C, Pélissier T, Fialip J, Wilcox G, Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Meth 1994, 32(4):197-200.